Faculty Appointments
Professor of Medicine
David E. Rogers Professorship
Education
M.D., Medicine, Columbia University, College of Physicians and Surgeons, New York, New YorkB.A., Chemistry, Colgate University, Colgate, New York
Office Address
A-2209 MCN
TN 2582
TN 2582
Publications
Blackman A, May S, Devasia RA, Maruri F, Stratton C, Sterling TR. Microcolonies in fluoroquinolone agar proportion susceptibility testing of Mycobacterium tuberculosis: an indicator of drug resistance. Eur. J. Clin. Microbiol. Infect. Dis [print-electronic]. 2012 Sep; 31(9): 2177-82. PMID: 22322359, PMCID: PMC3981548, DOI: 10.1007/s10096-012-1552-7, ISSN: 1435-4373.
Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf [print-electronic]. 2012 Jun; 21(6): 666-9. PMID: 22532509, PMCID: PMC3371104, DOI: 10.1002/pds.3243, ISSN: 1099-1557.
Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J. Antimicrob. Chemother [print-electronic]. 2012 Apr; 67(4): 819-31. PMID: 22279180, PMCID: PMC3299416, PII: dkr566, DOI: 10.1093/jac/dkr566, ISSN: 1460-2091.
Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, . Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin. Infect. Dis [print-electronic]. 2012 Apr; 54(7): 1026-34. PMID: 22291097, PMCID: PMC3297645, PII: cir1012, DOI: 10.1093/cid/cir1012, ISSN: 1537-6591.
Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility. J. Clin. Microbiol [print-electronic]. 2012 Apr; 50(4): 1390-6. PMID: 22189117, PMCID: PMC3318526, PII: JCM.05286-11, DOI: 10.1128/JCM.05286-11, ISSN: 1098-660X.
de Almeida AS, Fiske CT, Sterling TR, Kalams SA. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin. Vaccine Immunol [print-electronic]. 2012 Jan; 19(1): 45-52. PMID: 22038848, PMCID: PMC3255960, PII: CVI.05263-11, DOI: 10.1128/CVI.05263-11, ISSN: 1556-679X.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, . Three months of rifapentine and isoniazid for latent tuberculosis infection. N. Engl. J. Med. 2011 Dec 12/8/2011; 365(23): 2155-66. PMID: 22150035, DOI: 10.1056/NEJMoa1104875, ISSN: 1533-4406.
Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin. Infect. Dis [print-electronic]. 2011 Nov; 53(9): 952-60. PMID: 21946189, PMCID: PMC3189168, PII: cir606, DOI: 10.1093/cid/cir606, ISSN: 1537-6591.
Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, . Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J. Infect. Dis. 2011 Sep 9/15/2011; 204(6): 893-901. PMID: 21849286, PMCID: PMC3156918, PII: jir421, DOI: 10.1093/infdis/jir421, ISSN: 1537-6613.
Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB, Raffanti SP, Shepherd BE, Sterling TR. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?. J. Acquir. Immune Defic. Syndr. 2011 Aug 8/1/2011; 57(4): 305-10. PMID: 21423024, PMCID: PMC3141096, DOI: 10.1097/QAI.0b013e3182182e2d, ISSN: 1944-7884.
Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, Hong H, Bussmann H, Gaolathe T, McGowan CC, Sterling TR, Marlink RG. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS. 2011 Jul 7/31/2011; 25(12): 1471-9. PMID: 21572309, PMCID: PMC3188442, DOI: 10.1097/QAD.0b013e328347f9d4, ISSN: 1473-5571.
Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int. J. Tuberc. Lung Dis. 2011 Jul; 15(7): 906-11. PMID: 21682963, PMCID: PMC3172045, DOI: 10.5588/ijtld.10.0448, ISSN: 1815-7920.
Qian HZ, Stinnette SE, Rebeiro PF, Kipp AM, Shepherd BE, Samenow CP, Jenkins CA, No P, McGowan CC, Hulgan T, Sterling TR. The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abuse Treat [print-electronic]. 2011 Jul; 41(1): 14-20. PMID: 21349679, PMCID: PMC3110534, PII: S0740-5472(11)00014-6, DOI: 10.1016/j.jsat.2011.01.007, ISSN: 1873-6483.
McGowan CC, Weinstein DD, Samenow CP, Stinnette SE, Barkanic G, Rebeiro PF, Sterling TR, Moore RD, Hulgan T. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS ONE. 2011; 6(4): e18462. PMID: 21541016, PMCID: PMC3081810, DOI: 10.1371/journal.pone.0018462, ISSN: 1932-6203.
Oki NO, Motsinger-Reif AA, Antas PR, Levy S, Holland SM, Sterling TR. Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes. 2011; 4: 28. PMID: 21281516, PMCID: PMC3041678, PII: 1756-0500-4-28, DOI: 10.1186/1756-0500-4-28, ISSN: 1756-0500.
Alves TP, Hulgan T, Wu P, Sterling TR, Stinnette SE, Rebeiro PF, Vincz AJ, Bruce M, Ikizler TA. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol [print-electronic]. 2010 Dec; 5(12): 2269-75. PMID: 20876679, PMCID: PMC2994089, PII: CJN.00520110, DOI: 10.2215/CJN.00520110, ISSN: 1555-905X.
Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA, . Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010 Oct 10/23/2010; 24(16): 2469-79. PMID: 20829678, PMCID: PMC3136814, DOI: 10.1097/QAD.0b013e32833e6d14, ISSN: 1473-5571.
Shepherd BE, Jenkins CA, Rebeiro PF, Stinnette SE, Bebawy SS, McGowan CC, Hulgan T, Sterling TR. Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy. Epidemiology. 2010 Sep; 21(5): 698-705. PMID: 20585252, PMCID: PMC3086582, DOI: 10.1097/EDE.0b013e3181e97737, ISSN: 1531-5487.
Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clin. Infect. Dis. 2010 May 5/15/2010; 50 Suppl 3: S223-30. PMID: 20397952, DOI: 10.1086/651495, ISSN: 1537-6591.
Melekhin VV, Shepherd BE, Jenkins CA, Stinnette SE, Rebeiro PF, Bebawy SS, Rasbach DA, Hulgan T, Sterling TR. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. AIDS Patient Care STDS. 2010 May; 24(5): 279-86. PMID: 20438375, PMCID: PMC2875979, DOI: 10.1089/apc.2009.0283, ISSN: 1557-7449.
Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, Sterling TR. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med. Genet. 2010; 11: 37. PMID: 20196868, PMCID: PMC2837863, PII: 1471-2350-11-37, DOI: 10.1186/1471-2350-11-37, ISSN: 1471-2350.
Fiske CT, Griffin MR, Erin H, Warkentin J, Lisa K, Arbogast PG, Sterling TR. Black race, sex, and extrapulmonary tuberculosis risk: an observational study. BMC Infect. Dis. 2010; 10: 16. PMID: 20096113, PMCID: PMC2823615, PII: 1471-2334-10-16, DOI: 10.1186/1471-2334-10-16, ISSN: 1471-2334.
Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC, . CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?. AIDS Res Ther. 2010; 7: 45. PMID: 21159161, PMCID: PMC3022663, PII: 1742-6405-7-45, DOI: 10.1186/1742-6405-7-45, ISSN: 1742-6405.
Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M, . Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE. 2010; 5(5): e10753. PMID: 20505778, PMCID: PMC2873999, DOI: 10.1371/journal.pone.0010753, ISSN: 1932-6203.
Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am. J. Respir. Crit. Care Med [print-electronic]. 2009 Aug 8/15/2009; 180(4): 365-70. PMID: 19483111, PMCID: PMC2731810, PII: 200901-0146OC, DOI: 10.1164/rccm.200901-0146OC, ISSN: 1535-4970.
Melekhin VV, Shepherd BE, Stinnette SE, Rebeiro PF, Barkanic G, Raffanti SP, Sterling TR. Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response. PLoS ONE. 2009; 4(9): e6961. PMID: 19742315, PMCID: PMC2734183, DOI: 10.1371/journal.pone.0006961, ISSN: 1932-6203.
Fiske CT, Griffin MR, Mitchel E, Sterling TR, Grijalva CG. Accuracy of pharmacy and coded-diagnosis information in identifying tuberculosis in patients with rheumatoid arthritis. Pharmacoepidemiol Drug Saf [print-electronic]. 2012 Jun; 21(6): 666-9. PMID: 22532509, PMCID: PMC3371104, DOI: 10.1002/pds.3243, ISSN: 1099-1557.
Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system. J. Antimicrob. Chemother [print-electronic]. 2012 Apr; 67(4): 819-31. PMID: 22279180, PMCID: PMC3299416, PII: dkr566, DOI: 10.1093/jac/dkr566, ISSN: 1460-2091.
Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, Kirk GD, D'Souza G, Bosch RJ, Brooks JT, Napravnik S, Hessol NA, Jacobson LP, Kitahata MM, Klein MB, Moore RD, Rodriguez B, Rourke SB, Saag MS, Sterling TR, Gebo KA, Press N, Martin JN, Dubrow R, . Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin. Infect. Dis [print-electronic]. 2012 Apr; 54(7): 1026-34. PMID: 22291097, PMCID: PMC3297645, PII: cir1012, DOI: 10.1093/cid/cir1012, ISSN: 1537-6591.
Devasia R, Blackman A, Eden S, Li H, Maruri F, Shintani A, Alexander C, Kaiga A, Stratton CW, Warkentin J, Tang YW, Sterling TR. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility. J. Clin. Microbiol [print-electronic]. 2012 Apr; 50(4): 1390-6. PMID: 22189117, PMCID: PMC3318526, PII: JCM.05286-11, DOI: 10.1128/JCM.05286-11, ISSN: 1098-660X.
de Almeida AS, Fiske CT, Sterling TR, Kalams SA. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin. Vaccine Immunol [print-electronic]. 2012 Jan; 19(1): 45-52. PMID: 22038848, PMCID: PMC3255960, PII: CVI.05263-11, DOI: 10.1128/CVI.05263-11, ISSN: 1556-679X.
Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR, Chaisson RE, . Three months of rifapentine and isoniazid for latent tuberculosis infection. N. Engl. J. Med. 2011 Dec 12/8/2011; 365(23): 2155-66. PMID: 22150035, DOI: 10.1056/NEJMoa1104875, ISSN: 1533-4406.
Koethe JR, Jenkins CA, Shepherd BE, Stinnette SE, Sterling TR. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy. Clin. Infect. Dis [print-electronic]. 2011 Nov; 53(9): 952-60. PMID: 21946189, PMCID: PMC3189168, PII: cir606, DOI: 10.1093/cid/cir606, ISSN: 1537-6591.
Sterling TR, Lau B, Zhang J, Freeman A, Bosch RJ, Brooks JT, Deeks SG, French A, Gange S, Gebo KA, John Gill M, Horberg MA, Jacobson LP, Kirk GD, Kitahata MM, Klein MB, Martin JN, Rodriguez B, Silverberg MJ, Willig JH, Eron JJ, Goedert JJ, Hogg RS, Justice AC, McKaig RG, Napravnik S, Thorne J, Moore RD, . Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. J. Infect. Dis. 2011 Sep 9/15/2011; 204(6): 893-901. PMID: 21849286, PMCID: PMC3156918, PII: jir421, DOI: 10.1093/infdis/jir421, ISSN: 1537-6613.
Pettit AC, Jenkins CA, Stinnette SE, Rebeiro PF, Blackwell RB, Raffanti SP, Shepherd BE, Sterling TR. Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?. J. Acquir. Immune Defic. Syndr. 2011 Aug 8/1/2011; 57(4): 305-10. PMID: 21423024, PMCID: PMC3141096, DOI: 10.1097/QAI.0b013e3182182e2d, ISSN: 1944-7884.
Wester CW, Koethe JR, Shepherd BE, Stinnette SE, Rebeiro PF, Kipp AM, Hong H, Bussmann H, Gaolathe T, McGowan CC, Sterling TR, Marlink RG. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS. 2011 Jul 7/31/2011; 25(12): 1471-9. PMID: 21572309, PMCID: PMC3188442, DOI: 10.1097/QAD.0b013e328347f9d4, ISSN: 1473-5571.
Pettit AC, Kaltenbach LA, Maruri F, Cummins J, Smith TR, Warkentin JV, Griffin MR, Sterling TR. Chronic lung disease and HIV infection are risk factors for recurrent tuberculosis in a low-incidence setting. Int. J. Tuberc. Lung Dis. 2011 Jul; 15(7): 906-11. PMID: 21682963, PMCID: PMC3172045, DOI: 10.5588/ijtld.10.0448, ISSN: 1815-7920.
Qian HZ, Stinnette SE, Rebeiro PF, Kipp AM, Shepherd BE, Samenow CP, Jenkins CA, No P, McGowan CC, Hulgan T, Sterling TR. The relationship between injection and noninjection drug use and HIV disease progression. J Subst Abuse Treat [print-electronic]. 2011 Jul; 41(1): 14-20. PMID: 21349679, PMCID: PMC3110534, PII: S0740-5472(11)00014-6, DOI: 10.1016/j.jsat.2011.01.007, ISSN: 1873-6483.
McGowan CC, Weinstein DD, Samenow CP, Stinnette SE, Barkanic G, Rebeiro PF, Sterling TR, Moore RD, Hulgan T. Drug use and receipt of highly active antiretroviral therapy among HIV-infected persons in two U.S. clinic cohorts. PLoS ONE. 2011; 6(4): e18462. PMID: 21541016, PMCID: PMC3081810, DOI: 10.1371/journal.pone.0018462, ISSN: 1932-6203.
Oki NO, Motsinger-Reif AA, Antas PR, Levy S, Holland SM, Sterling TR. Novel human genetic variants associated with extrapulmonary tuberculosis: a pilot genome wide association study. BMC Res Notes. 2011; 4: 28. PMID: 21281516, PMCID: PMC3041678, PII: 1756-0500-4-28, DOI: 10.1186/1756-0500-4-28, ISSN: 1756-0500.
Alves TP, Hulgan T, Wu P, Sterling TR, Stinnette SE, Rebeiro PF, Vincz AJ, Bruce M, Ikizler TA. Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol [print-electronic]. 2010 Dec; 5(12): 2269-75. PMID: 20876679, PMCID: PMC2994089, PII: CJN.00520110, DOI: 10.2215/CJN.00520110, ISSN: 1555-905X.
Althoff KN, Justice AC, Gange SJ, Deeks SG, Saag MS, Silverberg MJ, Gill MJ, Lau B, Napravnik S, Tedaldi E, Klein MB, Gebo KA, . Virologic and immunologic response to HAART, by age and regimen class. AIDS. 2010 Oct 10/23/2010; 24(16): 2469-79. PMID: 20829678, PMCID: PMC3136814, DOI: 10.1097/QAD.0b013e32833e6d14, ISSN: 1473-5571.
Shepherd BE, Jenkins CA, Rebeiro PF, Stinnette SE, Bebawy SS, McGowan CC, Hulgan T, Sterling TR. Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy. Epidemiology. 2010 Sep; 21(5): 698-705. PMID: 20585252, PMCID: PMC3086582, DOI: 10.1097/EDE.0b013e3181e97737, ISSN: 1531-5487.
Sterling TR, Pham PA, Chaisson RE. HIV infection-related tuberculosis: clinical manifestations and treatment. Clin. Infect. Dis. 2010 May 5/15/2010; 50 Suppl 3: S223-30. PMID: 20397952, DOI: 10.1086/651495, ISSN: 1537-6591.
Melekhin VV, Shepherd BE, Jenkins CA, Stinnette SE, Rebeiro PF, Bebawy SS, Rasbach DA, Hulgan T, Sterling TR. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. AIDS Patient Care STDS. 2010 May; 24(5): 279-86. PMID: 20438375, PMCID: PMC2875979, DOI: 10.1089/apc.2009.0283, ISSN: 1557-7449.
Motsinger-Reif AA, Antas PR, Oki NO, Levy S, Holland SM, Sterling TR. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med. Genet. 2010; 11: 37. PMID: 20196868, PMCID: PMC2837863, PII: 1471-2350-11-37, DOI: 10.1186/1471-2350-11-37, ISSN: 1471-2350.
Fiske CT, Griffin MR, Erin H, Warkentin J, Lisa K, Arbogast PG, Sterling TR. Black race, sex, and extrapulmonary tuberculosis risk: an observational study. BMC Infect. Dis. 2010; 10: 16. PMID: 20096113, PMCID: PMC2823615, PII: 1471-2334-10-16, DOI: 10.1186/1471-2334-10-16, ISSN: 1471-2334.
Althoff KN, Gebo KA, Gange SJ, Klein MB, Brooks JT, Hogg RS, Bosch RJ, Horberg MA, Saag MS, Kitahata MM, Eron JJ, Napravnik S, Rourke SB, Gill MJ, Rodriguez B, Sterling TR, Deeks SG, Martin JN, Jacobson LP, Kirk GD, Collier AC, Benson CA, Silverberg MJ, Goedert JJ, McKaig RG, Thorne J, Rachlis A, Moore RD, Justice AC, . CD4 count at presentation for HIV care in the United States and Canada: are those over 50 years more likely to have a delayed presentation?. AIDS Res Ther. 2010; 7: 45. PMID: 21159161, PMCID: PMC3022663, PII: 1742-6405-7-45, DOI: 10.1186/1742-6405-7-45, ISSN: 1742-6405.
Nahid P, Bliven EE, Kim EY, Mac Kenzie WR, Stout JE, Diem L, Johnson JL, Gagneux S, Hopewell PC, Kato-Maeda M, . Influence of M. tuberculosis lineage variability within a clinical trial for pulmonary tuberculosis. PLoS ONE. 2010; 5(5): e10753. PMID: 20505778, PMCID: PMC2873999, DOI: 10.1371/journal.pone.0010753, ISSN: 1932-6203.
Devasia RA, Blackman A, Gebretsadik T, Griffin M, Shintani A, May C, Smith T, Hooper N, Maruri F, Warkentin J, Mitchel E, Sterling TR. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure. Am. J. Respir. Crit. Care Med [print-electronic]. 2009 Aug 8/15/2009; 180(4): 365-70. PMID: 19483111, PMCID: PMC2731810, PII: 200901-0146OC, DOI: 10.1164/rccm.200901-0146OC, ISSN: 1535-4970.
Melekhin VV, Shepherd BE, Stinnette SE, Rebeiro PF, Barkanic G, Raffanti SP, Sterling TR. Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response. PLoS ONE. 2009; 4(9): e6961. PMID: 19742315, PMCID: PMC2734183, DOI: 10.1371/journal.pone.0006961, ISSN: 1932-6203.